Skip to main content

Volume 33 - Issue 11 - November, 2021

11/01/2021
JIC November 2021 Table of Contents and Entire Issue PDF
JIC November 2021 Table of Contents and Entire Issue PDF
JIC November 2021 Table of...
11/01/2021
Journal of Invasive Cardiology

Feature

Original Contribution
11/01/2021
Dr. Mariani and colleagues retrospectively evaluated 70 plaques with PR at the FD-OCT (25 in stable CAD patients and 45 in NSTEMI patients). Main clinical, angiographic, and morphological features were compared.
Dr. Mariani and colleagues retrospectively evaluated 70 plaques with PR at the FD-OCT (25 in stable CAD patients and 45 in NSTEMI patients). Main clinical, angiographic, and morphological features were compared.
Dr. Mariani and colleagues...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021
A prospective analysis of 71 non-consecutive patients who underwent LAAO over an 18-month period with cardiac CTA-guided preprocedural planning and ICE was conducted.
A prospective analysis of 71 non-consecutive patients who underwent LAAO over an 18-month period with cardiac CTA-guided preprocedural planning and ICE was conducted.
A prospective analysis of 71...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021
The PREVAIL study evaluated the safety and effectiveness of a paclitaxel DCB for the treatment of coronary de novo and ISR lesions in patients with symptomatic ischemic heart disease.
The PREVAIL study evaluated the safety and effectiveness of a paclitaxel DCB for the treatment of coronary de novo and ISR lesions in patients with symptomatic ischemic heart disease.
The PREVAIL study evaluated the...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021
A retrospective analysis of consecutive patients who underwent concurrent percutaneous PFO closure and coronary angiography was performed.
A retrospective analysis of consecutive patients who underwent concurrent percutaneous PFO closure and coronary angiography was performed.
A retrospective analysis of...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021
Dr. Fu and colleagues evaluated MACE and hemorrhagic event rates for an antithrombotic regimen using bivalirudin or UFH during PCI in ACS patients.
Dr. Fu and colleagues evaluated MACE and hemorrhagic event rates for an antithrombotic regimen using bivalirudin or UFH during PCI in ACS patients.
Dr. Fu and colleagues evaluated...
11/01/2021
Journal of Invasive Cardiology
Brief Contribution
11/01/2021
Six mechanisms appear to explain poor response to coronary sinus reducer therapy. We hereby review these mechanisms in detail and highlight key areas that should be addressed in order to try and reduce the burden of non-responders following...
Six mechanisms appear to explain poor response to coronary sinus reducer therapy. We hereby review these mechanisms in detail and highlight key areas that should be addressed in order to try and reduce the burden of non-responders following...
Six mechanisms appear to explain...
11/01/2021
Journal of Invasive Cardiology
Original Contribution
11/01/2021
Journal of Invasive Cardiology